Quote:May’s Seriously Downbeat Jobs Report Puts Kibosh on Fed Rate Hike; Underscores Need for Deep Infrastructure Dive
MIGHT be a good time to build and repair sh*t the way we used to without LOSING our sh*t over necessary spending, and before there was a Black president!
06/03/2016 10:15 am ET | Updated 6 hours ago
Jared Bernstein
Fmr. Obama administration economist; CNBC and MSNBC contributor
In an unexpectedly downbeat jobs report, employers added only 38,000 jobs last month, the worst month for job gains since employment started recovering in 2010. Downward revisions trimmed the employment gains for the prior two months by 59,000, and the labor force participation rate fell again in May, as it had in April. That drove the unemployment rate down to a recovery low of 4.7 percent, but for the wrong reason: not because of people getting jobs but because of people leaving the job market.
Given the volatility in these monthly reports, I have been appropriately cautious in suggesting that the U.S. job engine has truly downshifted.
However, a look at JB’s monthly smoother now at least tentatively supports that conclusion. Going from 12, to 6, to 3 month averages of monthly job gains shows a steady deceleration from 200,000 to 116,000.
![]()
Source: BLS, my calculations.
This new, slower trend could, of course, reverse if growth picks up and part of May’s very low topline number is due to the strike at Verizon, a one-off event which, according to the Bureau, reduced the payroll count by about 35,000. But even adding those information workers back into May’s tally, the three-month bar in the smoother would rise to 127,000, still well below the 200,000 trend over the last 12 months.
The negative report surely puts the nail in the coffin of a Fed rate hike at their meeting later this month. Prior to the report, the futures market probability of a June hike was about 20 percent. After the release, it quickly fell to 4 percent.
Weak job creation is weighing on the labor force participation rate, which is down 0.4 tenths of a percent over the last two months. At 62.6 percent, the LFPR is back to where it was last December. While retiring baby-boomers have been correctly cited as a structural—vs. cyclical—factor lowering participation, the recent decline has also occurred among “prime-age” workers, those 25-54. In other words, what we’re seeing here is more than a benign, demographic trend; it’s a trend that is also a function of weak labor demand failing to pull people into to the job market.
Most goods-producing industries shed jobs in May, including durable manufacturing, down 18,000. Over the past 12 months, this important manufacturing sub-sector has shed 80,000 jobs, a sharp reversal from the addition of 120,000 jobs in the prior 12 months. The stronger dollar, which makes our exports less price-competitive, is a major factor in this unfortunate turnaround.
Another sign of weak labor demand was the increase in involuntary part-timers — i.e., those who would prefer full-time jobs — by 470,000. Again, the monthly series is noisy, so we should discount the large jump, but the underemployment rate, which includes these workers, remains stuck at 9.7 percent, at least a point above where it would be in a full-employment job market.
There were some bright spots in the report. Job creation in health care continues to churn along, with employment up 46,000 last month and about 490,000 over the past year. As we’ve shown, this favorable trend coincided with the advent of health care reform’s premium subsidies and Medicaid expansion; it’s unlikely that’s a coincidence.
The unemployment rate for workers with at least some college attainment held at lower than average rates of about 4 percent for those with some college and 2.4 percent for those with college degrees, and their LFPRs did not fall in May.
Finally, wage growth rose a mild 0.2 percent over the month, but is up 2.5 percent over the past year. That’s an acceleration over the 2 percent growth rate that prevailed last year at around this time.
The lower trend in job creation that appears to have taken hold could, as noted, reverse. Real GDP growth in the first quarter of the year was less than 1 percent, and current forecasts for the second quarter are tracking well above that. Then there’s the strike, and weather issues could also be adding noise to the data.
But it would be a mistake to write off these dour numbers. Moreover, while the Fed can certainly do no harm by holding rates steady, that’s not the same as helping.
Fiscal policy is looking more and more like an essential, missing ingredient in labor demand, and with borrowing costs still as low as they are, a smart move by policy makers would be to quickly start up an infrastructure program, perhaps in areas of water safety or repairing our deteriorating stock of public schools.
Clearly, in the midst of both political dysfunction and a contentious election, this would be a heavy political lift. But it’s still the right thing to do.
http://www.huffingtonpost.com/jared-bernstein...78700.html
Frank Cook · President at Association Computer Services
The Republicans have been blocking all spending and then blaming Obama for the stagnant economy which their obstructionism has produced. Trump has, however, called for infrastructure spending.
Democrats need to call his bluff. Introduce a clean infrastructure spending bill that does only what Trump says we should do, and then be ready on the debate trail when Paul Ryan refuses to bring it to a vote.
May’s Seriously Downbeat Jobs Report Puts Kibosh on Fed
Top 10 Most Recent News Articles
Master Sommeliers and Italian Producers Clash on Wine Lists
Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...
Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment
Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...
Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness
A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...
Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move
Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...
Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians
Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...
Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies
Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...
Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study
Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...
Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC
Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...
Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC
Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...
Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices
Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...
Continue ReadingTop 5 Most Recently Viewed Articles
VENU Embraces Blockchain: A New Era for Live Events
VENU's Groundbreaking Blockchain Initiative in Live Entertainment In a significant move that signals the future of live entertainment, VENU (NYSE American: VENU), a leading operator of premium venues across the country, has announced an innovative blockchain-powered platform set to launch in 2026. This strategy is revolutionary, intending to blend physical experiences...
Continue Reading
Empowering Leadership Transitions at Ora Enhance Customer Focus
Empowering Strategic Leadership at Ora Ora, an esteemed player in the field of ophthalmic contract research organizations (CROs), has recently appointed Cindy Markham as its new Chief Commercial Officer. This strategic move underscores Ora's dedication to enhancing the customer experience, setting a new benchmark in the ophthalmic research sector. Commitment to Customer...
Continue Reading
Real Matters Announces Online Annual General Meeting Details
Virtual Annual General Meeting Scheduled for Shareholders Real Matters Inc., a prominent network management services provider, has announced the date for its upcoming Annual General Meeting (AGM). The meeting is set to take place on a Thursday morning, providing a convenient option for shareholders to participate from the comfort of their homes. Accessing the AGM Online...
Continue Reading
Trinity Biotech Triumphs in Nasdaq Compliance Journey
Trinity Biotech Celebrates Nasdaq Compliance Achievement Trinity Biotech plc (Nasdaq Global Select: TRIB), a leading name in biotechnology focused on human diagnostics and diabetes management solutions, including innovative wearable biosensors, has reached a significant milestone. The company recently announced it has regained compliance with the minimum market value of...
Continue Reading
Vaycaychella Transitions to Great Estate Blockchains Inc
Vaycaychella Unveils a Bold New Identity Vaycaychella, Inc. (OTC Pink: VAYK) has officially announced a name change to "Great Estate Blockchains Inc." This transition signifies a rejuvenated focus on enhancing the value of historic landmarks through innovative cryptocurrency strategies. The company aims to tap into a colossal market, potentially valued in the hundreds of...
Continue Reading